knowledge
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
Next article: Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
hotspot
entertainment
-
ER docs worry over extreme heat as a 'mass casualty event'
2025-09-30 21:18 -
US soldier in North Korean custody after crossing DMZ line
2025-09-30 20:23 -
FDA approves Eli Lilly ulcerative colitis treatment Omvoh
2025-09-30 20:21 -
Twill hunts for pharma partner to market its depression app
2025-09-30 20:21 -
Eli Lilly to pay $200M for Beam’s stake in gene
2025-09-30 20:16 -
BridgeBio heart drug succeeds in pivotal study
2025-09-30 20:02